Pfizer Launches Telehealth Website for Migraine and Respiratory Products

Aug 27, 2024, 11:57 AM

Pfizer Inc is taking a new approach to address the declining demand for its Covid products by launching a direct-to-consumer model. The company has introduced a new website aimed at promoting and improving access to its health care offerings, specifically targeting migraine and respiratory illnesses. This initiative is part of a broader trend among major drugmakers to utilize telehealth platforms to reach patients directly. The website, named 'PfizerForAll', will also facilitate the direct sale of common vaccines and medicines, bypassing traditional middlemen. This strategy reflects a growing trend in the pharmaceutical industry to pair telehealth services with drug sales to enhance patient access and boost sales. $PFE (+0.1% pre)